Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | NASDAQ | Biotechnology | $1.73B | $33.48 | 9.99% | $28.99M | 83.70x | 0.25 | United States | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $43.88B | $330.87 | 4.68% | $631.44M | 138.44x | 5.29 | United States | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $547.19M | $9.32 | 6.15% | $99.31M | 6.66x | 0.84 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $2.15B | $9.01 | -1.53% | $197.86M | 14.53x | 0.31 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $4.29B | $40.31 | 5.75% | $45.21M | 42.43x | 0.29 | United States | ||
| ABEO | ABEONA THERAPEUTICS INC | NASDAQ | Biotechnology | $255.58M | $4.48 | 5.91% | $78.59M | 3.34x | 0.38 | United States | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.63B | $64.63 | 4.02% | $573.05M | 24.48x | 50.73 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $7.55B | $258.32 | 4.61% | $196.02M | 36.49x | 0.09 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $353.15M | $4.41 | 3.04% | $19.64M | 20.05x | 0.39 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $27.67B | $47.97 | 3.45% | $1.08B | 26.80x | 1.02 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.63B | $32.17 | 5.30% | $34.90M | 97.48x | 0.38 | United States | ||
| APLS | APELLIS PHARMACEUTICALS INC | NASDAQ | Biotechnology | $5.14B | $40.23 | 135.40% | $70.00M | 223.50x | 1.91 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.62B | $28.01 | 4.13% | $255.05M | 10.15x | 0.46 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $754.85M | $2.45 | 3.38% | $52.93M | 122.50x | -16.53 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $8.18B | $52.26 | 0.42% | $226.43M | 100.50x | 0.25 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.86B | $56.49 | 3.10% | $572.94M | 31.04x | 0.25 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $11.14B | $42.89 | 2.24% | $994.49M | 14.89x | 0.32 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.56B | $32.21 | 5.81% | $92.61M | 38.35x | 0.07 | United States | ||
| XOMA | XOMA ROYALTY CORP | NASDAQ | Biotechnology | $373.48M | $31.37 | 3.70% | $34.69M | 20.50x | 2.01 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $81.68B | $772.64 | 3.12% | $5.82B | 17.94x | 0.30 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.02B | $24.76 | 4.12% | $321.68M | 14.15x | 0.16 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $113.44B | $446.54 | 0.76% | $4.87B | 28.88x | 0.37 | United States | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.98B | $199.65 | 3.64% | $199.39M | 31.00x | 0.53 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $25.99B | $592.98 | 0.79% | $1.82B | 19.68x | 0.11 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $18.73B | $94.12 | 4.20% | $1.76B | 14.28x | 0.35 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $536.75M | $6.79 | 3.35% | $167.35M | 3.02x | 1.04 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $586.84M | $3.95 | 2.33% | $79.47M | 11.97x | 0.34 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.